메뉴 건너뛰기




Volumn 8, Issue 2, 2013, Pages

Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; PEGINTERFERON ALPHA2A; RIBAVIRIN; SOLUBLE CD26 ANTIGEN; UNCLASSIFIED DRUG;

EID: 84874247593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056991     Document Type: Article
Times cited : (9)

References (39)
  • 1
    • 77958614232 scopus 로고    scopus 로고
    • Hepatitis C treatment: current and future perspectives
    • Munir S, Saleem S, Idrees M, Tariq A, Butt S, et al. (2010) Hepatitis C treatment: current and future perspectives. Virol J 7: 296.
    • (2010) Virol J , vol.7 , pp. 296
    • Munir, S.1    Saleem, S.2    Idrees, M.3    Tariq, A.4    Butt, S.5
  • 2
    • 1842480410 scopus 로고    scopus 로고
    • Host factors and failure of interferon-alpha treatment in hepatitis C virus
    • Gao B, Hong F, Radaeva S, (2004) Host factors and failure of interferon-alpha treatment in hepatitis C virus. Hepatology 39: 880-890.
    • (2004) Hepatology , vol.39 , pp. 880-890
    • Gao, B.1    Hong, F.2    Radaeva, S.3
  • 3
    • 70349292099 scopus 로고    scopus 로고
    • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
    • Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
    • (2009) Nature , vol.461 , pp. 399-401
    • Ge, D.1    Fellay, J.2    Thompson, A.J.3    Simon, J.S.4    Shianna, K.V.5
  • 4
    • 70349548852 scopus 로고    scopus 로고
    • IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
    • Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
    • (2009) Nat Genet , vol.41 , pp. 1100-1104
    • Suppiah, V.1    Moldovan, M.2    Ahlenstiel, G.3    Berg, T.4    Weltman, M.5
  • 5
    • 70349533037 scopus 로고    scopus 로고
    • Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
    • Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 41: 1105-1109.
    • (2009) Nat Genet , vol.41 , pp. 1105-1109
    • Tanaka, Y.1    Nishida, N.2    Sugiyama, M.3    Kurosaki, M.4    Matsuura, K.5
  • 6
    • 70349966196 scopus 로고    scopus 로고
    • Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
    • Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
    • (2009) Nature , vol.461 , pp. 798-801
    • Thomas, D.L.1    Thio, C.L.2    Martin, M.P.3    Qi, Y.4    Ge, D.5
  • 10
    • 77951576906 scopus 로고    scopus 로고
    • Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C
    • Askarieh G, Alsio A, Pugnale P, Negro F, Ferrari C, et al. (2010) Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology. 51: 1523-1530.
    • (2010) Hepatology , vol.51 , pp. 1523-1530
    • Askarieh, G.1    Alsio, A.2    Pugnale, P.3    Negro, F.4    Ferrari, C.5
  • 11
    • 23744481169 scopus 로고    scopus 로고
    • Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
    • Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, et al. (2005) Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood. 106: 1175-1182.
    • (2005) Blood , vol.106 , pp. 1175-1182
    • Butera, D.1    Marukian, S.2    Iwamaye, A.E.3    Hembrador, E.4    Chambers, T.J.5
  • 12
    • 33144462713 scopus 로고    scopus 로고
    • Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
    • Diago M, Castellano G, Garcia-Samaniego J, Perez C, Fernandez I, et al. (2006) Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut. 55: 374-379.
    • (2006) Gut , vol.55 , pp. 374-379
    • Diago, M.1    Castellano, G.2    Garcia-Samaniego, J.3    Perez, C.4    Fernandez, I.5
  • 13
    • 79952097683 scopus 로고    scopus 로고
    • Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B Related Single Nucleotide Polymorphisms
    • Lagging M, Askarieh G, Negro F, Bibert S, Soderholm J, et al. (2011) Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B Related Single Nucleotide Polymorphisms. PLoS ONE 6: e17232.
    • (2011) PLoS ONE , vol.6
    • Lagging, M.1    Askarieh, G.2    Negro, F.3    Bibert, S.4    Soderholm, J.5
  • 14
    • 33845662689 scopus 로고    scopus 로고
    • IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
    • Lagging M, Romero AI, Westin J, Norkrans G, Dhillon AP, et al. (2006) IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44: 1617-1625.
    • (2006) Hepatology , vol.44 , pp. 1617-1625
    • Lagging, M.1    Romero, A.I.2    Westin, J.3    Norkrans, G.4    Dhillon, A.P.5
  • 15
    • 33749017951 scopus 로고    scopus 로고
    • Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection
    • Romero AI, Lagging M, Westin J, Dhillon AP, Dustin LB, et al. (2006) Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 194: 895-903.
    • (2006) J Infect Dis , vol.194 , pp. 895-903
    • Romero, A.I.1    Lagging, M.2    Westin, J.3    Dhillon, A.P.4    Dustin, L.B.5
  • 16
    • 79960382329 scopus 로고    scopus 로고
    • IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C
    • Bochud PY, Bibert S, Negro F, Haagmans B, Soulier A, et al. (2011) IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. J Hepatol.
    • (2011) J Hepatol
    • Bochud, P.Y.1    Bibert, S.2    Negro, F.3    Haagmans, B.4    Soulier, A.5
  • 17
    • 0035254238 scopus 로고    scopus 로고
    • Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadelta+ T cells, and natural killer-type cells in human thymus
    • Romagnani P, Annunziato F, Lazzeri E, Cosmi L, Beltrame C, et al. (2001) Interferon-inducible protein 10, monokine induced by interferon gamma, and interferon-inducible T-cell alpha chemoattractant are produced by thymic epithelial cells and attract T-cell receptor (TCR) alphabeta+ CD8+ single-positive T cells, TCRgammadelta+ T cells, and natural killer-type cells in human thymus. Blood 97: 601-607.
    • (2001) Blood , vol.97 , pp. 601-607
    • Romagnani, P.1    Annunziato, F.2    Lazzeri, E.3    Cosmi, L.4    Beltrame, C.5
  • 18
    • 63349107684 scopus 로고    scopus 로고
    • Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis
    • Denney H, Clench MR, Woodroofe MN, (2009) Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and-9: implications for chemotaxis. Biochem Biophys Res Commun 382: 341-347.
    • (2009) Biochem Biophys Res Commun , vol.382 , pp. 341-347
    • Denney, H.1    Clench, M.R.2    Woodroofe, M.N.3
  • 19
    • 0035895070 scopus 로고    scopus 로고
    • Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
    • Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, et al. (2001) Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554-3561.
    • (2001) Blood , vol.98 , pp. 3554-3561
    • Proost, P.1    Schutyser, E.2    Menten, P.3    Struyf, S.4    Wuyts, A.5
  • 20
    • 78650962504 scopus 로고    scopus 로고
    • Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
    • Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, et al. (2011) Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest 121: 308-317.
    • (2011) J Clin Invest , vol.121 , pp. 308-317
    • Casrouge, A.1    Decalf, J.2    Ahloulay, M.3    Lababidi, C.4    Mansour, H.5
  • 22
    • 0035834010 scopus 로고    scopus 로고
    • CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO
    • Ishii T, Ohnuma K, Murakami A, Takasawa N, Kobayashi S, et al. (2001) CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc Natl Acad Sci U S A 98: 12138-12143.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 12138-12143
    • Ishii, T.1    Ohnuma, K.2    Murakami, A.3    Takasawa, N.4    Kobayashi, S.5
  • 23
    • 0035892903 scopus 로고    scopus 로고
    • Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs
    • Ohnuma K, Munakata Y, Ishii T, Iwata S, Kobayashi S, et al. (2001) Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs. J Immunol 167: 6745-6755.
    • (2001) J Immunol , vol.167 , pp. 6745-6755
    • Ohnuma, K.1    Munakata, Y.2    Ishii, T.3    Iwata, S.4    Kobayashi, S.5
  • 24
    • 33750691709 scopus 로고    scopus 로고
    • PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion
    • Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, et al. (2006) PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. Journal of virology 80: 11398-11403.
    • (2006) Journal of Virology , vol.80 , pp. 11398-11403
    • Urbani, S.1    Amadei, B.2    Tola, D.3    Massari, M.4    Schivazappa, S.5
  • 25
    • 0037105567 scopus 로고    scopus 로고
    • Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection
    • Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, et al. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447-3458.
    • (2002) J Immunol , vol.169 , pp. 3447-3458
    • Wedemeyer, H.1    He, X.S.2    Nascimbeni, M.3    Davis, A.R.4    Greenberg, H.B.5
  • 26
    • 44849113503 scopus 로고    scopus 로고
    • Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences
    • Golden-Mason L, Klarquist J, Wahed AS, Rosen HR, (2008) Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. J Immunol 180: 3637-3641.
    • (2008) J Immunol , vol.180 , pp. 3637-3641
    • Golden-Mason, L.1    Klarquist, J.2    Wahed, A.S.3    Rosen, H.R.4
  • 27
    • 0029151623 scopus 로고
    • Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
    • Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, et al. (1995) Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007.
    • (1995) Lancet , vol.346 , pp. 1006-1007
    • Diepolder, H.M.1    Zachoval, R.2    Hoffmann, R.M.3    Wierenga, E.A.4    Santantonio, T.5
  • 28
    • 34848870230 scopus 로고    scopus 로고
    • HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project)
    • Pilli M, Zerbini A, Penna A, Orlandini A, Lukasiewicz E, et al. (2007) HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project). Gastroenterology 133: 1132-1143.
    • (2007) Gastroenterology , vol.133 , pp. 1132-1143
    • Pilli, M.1    Zerbini, A.2    Penna, A.3    Orlandini, A.4    Lukasiewicz, E.5
  • 29
    • 21844477610 scopus 로고    scopus 로고
    • International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C
    • Zeuzem S, Pawlotsky JM, Lukasiewicz E, von Wagner M, Goulis I, et al. (2005) International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. J Hepatol. 43: 250-257.
    • (2005) J Hepatol , vol.43 , pp. 250-257
    • Zeuzem, S.1    Pawlotsky, J.M.2    Lukasiewicz, E.3    von Wagner, M.4    Goulis, I.5
  • 30
    • 24644507185 scopus 로고    scopus 로고
    • Genotyping of hepatitis C virus by Taqman real-time PCR
    • Lindh M, Hannoun C, (2005) Genotyping of hepatitis C virus by Taqman real-time PCR. J Clin Virol 34: 108-114.
    • (2005) J Clin Virol , vol.34 , pp. 108-114
    • Lindh, M.1    Hannoun, C.2
  • 31
    • 79959587024 scopus 로고    scopus 로고
    • IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1
    • Lindh M, Lagging M, Arnholm B, Eilard A, Nilsson S, et al. (2011) IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1. J Viral Hepat 18: e325-331.
    • (2011) J Viral Hepat , vol.18
    • Lindh, M.1    Lagging, M.2    Arnholm, B.3    Eilard, A.4    Nilsson, S.5
  • 32
    • 84874229764 scopus 로고    scopus 로고
    • eBioscience, Access. Available
    • eBioscience. Human sCD26 Platinum ELISA.Access. Available: http://www.bendermedsystems.org/bm_products/MAN/235CE.pdf. Accessed 2012 Dec 10.
    • Human sCD26 Platinum
  • 33
    • 84874279004 scopus 로고    scopus 로고
    • Access. Available
    • Systems RD. Human CXCL10/IP-10 Immunoassay.Access. Available: http://www.rndsystems.com/pdf/dip100.pdf. Accessed 2012 Dec 10.
    • Human CXCL10/IP-10 Immunoassay
  • 35
    • 0029028843 scopus 로고
    • A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests
    • Greiner M, Sohr D, Gobel P, (1995) A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 185: 123-132.
    • (1995) J Immunol Methods , vol.185 , pp. 123-132
    • Greiner, M.1    Sohr, D.2    Gobel, P.3
  • 36
    • 0029075943 scopus 로고
    • Two-graph receiver operating characteristic (TG-ROC): a Microsoft-EXCEL template for the selection of cut-off values in diagnostic tests
    • Greiner M, (1995) Two-graph receiver operating characteristic (TG-ROC): a Microsoft-EXCEL template for the selection of cut-off values in diagnostic tests. J Immunol Methods 185: 145-146.
    • (1995) J Immunol Methods , vol.185 , pp. 145-146
    • Greiner, M.1
  • 37
    • 79953325779 scopus 로고    scopus 로고
    • Novel aspects of cellular action of dipeptidyl peptidase IV/CD26
    • Ansorge S, Nordhoff K, Bank U, Heimburg A, Julius H, et al. (2011) Novel aspects of cellular action of dipeptidyl peptidase IV/CD26. Biol Chem 392: 153-168.
    • (2011) Biol Chem , vol.392 , pp. 153-168
    • Ansorge, S.1    Nordhoff, K.2    Bank, U.3    Heimburg, A.4    Julius, H.5
  • 38
    • 0034948257 scopus 로고    scopus 로고
    • Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C
    • Firneisz G, Lakatos PL, Szalay F, (2001) Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C. Scand J Gastroenterol. 36: 877-880.
    • (2001) Scand J Gastroenterol , vol.36 , pp. 877-880
    • Firneisz, G.1    Lakatos, P.L.2    Szalay, F.3
  • 39
    • 77951258833 scopus 로고    scopus 로고
    • Features of responding T cells in cancer and chronic infection
    • Kim PS, Ahmed R, (2010) Features of responding T cells in cancer and chronic infection. Curr Opin Immunol 22: 223-230.
    • (2010) Curr Opin Immunol , vol.22 , pp. 223-230
    • Kim, P.S.1    Ahmed, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.